Pharmacokinetics of Sufentanil Sublingual Microtablet 30 mcg and 15 mcg in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 07 Jan 2015
At a glance
- Drugs Sufentanil (Primary) ; Sufentanil (Primary)
- Indications Acute pain; Cancer pain; Postoperative pain
- Focus Pharmacokinetics
- Sponsors AcelRx Pharmaceuticals
- 14 May 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 06 May 2014 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 14 Mar 2014 New trial record